Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Orion to receive an upfront payment of USD 290 million
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Advancing to IND-enabling studies with multiple drug candidates
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
Syngene's collaboration with Zoetis started in 2011
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Subscribe To Our Newsletter & Stay Updated